The epidemiology of influenza viruses in humans

Hot Topics in Respiratory Medicine

Volumn , Issue 13, 2010, Pages 7-14

  Fraaij, Pieter L A ^a   Osterhaus, Albert D M E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENIC DRIFT; ANTIGENIC SHIFT; ARTICLE; AVIAN INFLUENZA; CLINICAL FEATURE; EPIDEMIC; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLUENZA; INFLUENZA A; INFLUENZA B; INFLUENZA C; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N7; INFLUENZA VIRUS B; INFLUENZA VIRUS C; NONHUMAN; PANDEMIC INFLUENZA; SYMPTOMATOLOGY; VIRUS MUTATION; VIRUS STRAIN; VIRUS TRANSMISSION; ZOONOSIS;

EID: 79957441813     PISSN: 19739664     EISSN: 20360886     Source Type: Book Series    
DOI: 10.4147/htr-091307     Document Type: Article

References (64)

1. Shope R.E. The etiology of swine influenza. Science 1931;73:214-215.
2. Wright P.F, Neumann G, Kawaoka Y. Orthomyxoviruses. In: Knipe DM, ed. Field's Virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007:1692-1727.
3. Strauss J.H, Strauss E.G. Family Orthomyxoviridae. In: Strauss JH, Strauss EG, eds. Viruses and Human Disease. London: Elsevier Academic Press publications; 2008:162-175.
4. Webster R.G, Bean W.J, Gorman O.T, Chambers T.M, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992;56:152-179.
5. Bodewes R, Kreijtz J.H, Rimmelzwaan G.F. Yearly influenza vaccinations: a double-edged sword? Lancet Infect Dis 2009;9:784-788.
6. Thompson W.W, Shay D.K, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-186.
7. Morens D.M, Taubenberger J.K, Fauci A.S. The persistent legacy of the 1918 influenza virus. N Engl J Med 2009;361:225-229.
8. Sauerbrei A, Schmidt-Ott R, Hoyer H, Wutzler P. Seroprevalence of influenza A and B in German infants and adolescents. Med Microbiol Immunol 2009;198:93-101.
9. Yang Y, Sugimoto J.D, Halloran M.E, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009;326:729-733.
10. Thompson W.W, Shay D.K, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292:1333-1340.
11. Poehling K.A, Edwards K.M, Weinberg G.A, et al; New Vaccine Surveillance Network. The underrecognized burden of influenza in young children. N Engl J Med 2006;355:31-40.
12. Glezen W.P, Paredes A, Taber L.H. Influenza in children. Relationship to other respiratory agents. JAMA 1980;243:1345-1349.
13. Jansen A.G, Sanders E.A, Hoes A.W, van Loon A.M, Hak E. Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J 2007;30:1158-1166.
14. Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008;122:805-811.
15. Glezen W.P, Taber L.H, Frank A.L, Gruber W.C, Piedra P.A. Influenza virus infections in infants. Pediatr Infect Dis J 1997;16:1065-1068.
16. Ahmed R, Oldstone M.B, Palese P. Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat Immunol 2007;8:1188-1193.
17. Taubenberger J.K, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis 2006;12:15-22.
18. Claas E.C, Osterhaus A.D, van Beek R, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998;351:472-477.
19. Uyeki T.M. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 2009;49:279-290.
20. Gambotto A, Barratt-Boyes S.M, de Jong M.D, Neumann G, Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008;371:1464-1475.
21. Shortridge K.F, Zhou N.N, Guan Y, et al. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 1998;252:331-342.
22. Peiris J.S, Yu W.C, Leung C.W, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004;363:617-619.
23. WHO. http://www.who.int/csr/disease/avian_influenza/country/cases_table_2009_09_24/en/index.html. 2009 (Accessed November 23, 2009)
24. Katz J.M, Lim W, Bridges C.B, et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 1999;180:1763-1770.
25. Chan P.K. Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 2002;34 Suppl 2:S58-S64.
26. Vong S, Ly S, Van Kerkhove M.D, et al. Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus--Cambodia, 2006. J Infect Dis 2009;199:1744-1752.
27. Arabi Y, Gomersall CD, Ahmed QA, Boynton BR, Memish ZA. The critically ill avian influenza A (H5N1) patient. Crit Care Med 2007;35:1397-1403.
28. Ungchusak K, Auewarakul P, Dowell S F, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005;352:333-340.
29. Buxton Bridges C, Katz JM, Seto WH, et al. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis 2000;181:344-348.
30. Meijer A, Bosman A, van de Kamp EE, Wilbrink B, Du Ry van Beest Holle M, Koopmans M. Measurement of antibodies to avian influenza virus A (H7N7) in humans by hemagglutination inhibition test. J Virol Methods 2006;132:113-120.
31. Fouchier R.A, Schneeberger P.M, Rozendaal F.W, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 2004;101:1356-1361.
32. Taubenberger J.K, Reid A.H, Lourens R.M, Wang R, Jin G, Fanning T.G. Characterization of the 1918 influenza virus polymerase genes. Nature 2005;437:889-893.
33. Potter C.W. A history of influenza. J Appl Microbiol 2001;91:572-579.
34. Gatherer D. The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol 2009;45:174-178.
35. Beveridge W.I. The chronicle of influenza epidemics. Hist Philos Life Sci 1991;13:223-234.
36. Gibbs M.J, Gibbs A.J. Molecular virology: was the 1918 pandemic caused by a bird fu? Nature 2006;440:E8; discussion E9-10.
37. Antonovics J, Hood ME, Baker CH. Molecular virology: was the 1918 fu avian in origin? Nature 2006;440:E9; discussion E9-10.
38. Johnson N.P, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 2002;76:105-115.
39. Reid A.H, Taubenberger J.K, Fanning T.G. Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus. Nat Rev Microbiol 2004;2:909-914.
40. Starr I. Influenza in 1918: recollections of the epidemic in Philadelphia. Ann Intern Med 1976;85:516-518.
41. Simonsen L, Clarke M.J, Schonberger L.B, Arden N.H, Cox N.J, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998;178:53-60.
42. Langford C. The age pattern of mortality in the 1918-19 influenza pandemic: an attempted explanation based on data for England and Wales. Med Hist 2002;46:1-20.
43. Feigin R.D, Cherry J, Demmler-Harrison G.J, Kaplan S.L. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia: W.B. Saunders; 2004.
44. Stadler K, Masignani V, Eickmann M, et al. SARS-beginning to understand a new virus. Nat Rev Microbiol 2003;1:209-218.
45. Garten R.J, Davis C.T, Russell C.A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009;325:197-201.
46. Kilbourne E.D. Influenza pandemics of the 20th century. Emerg Infect Dis 2006;12:9-14.
47. Dawood F.S, Jain S, Finelli L, et al; Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360: 2605-2615.
48. Smith G.J, Vijaykrishna D, Bahl J, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009;459:1122-1125.
49. Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009;460:1021-1025.
50. Fraser C, Donnelly C.A, Cauchemez S, et al. Pandemic potential of a strain of influenza A (H1N1): early fndings. Science 2009;324:1557-1561.
51. WHO. Pandemic (H1N1) 2009 - update 76. http://www.who.int/csr/don/2009_11_27a/en/index.html. 2009 (Accessed November 28, 2009).
52. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361:1945-1952.
53. Vaillant L, La Ruche G, Tarantola A, Barboza P; Epidemic Intelligence Team at InVS. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009;14:pii:19309.
54. Chowell G, Bertozzi S.M, Colchero M.A, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009;361:674-679.
55. La Ruche G, Tarantola A, Barboza P, Vaillant L, Gueguen J, Gastellu-Etchegorry M; Epidemic Intelligence Team at InVS. The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. Euro Surveill 2009;14:pii:19366.
56. ECDC. http://www.ecdc.europa.eu/en/healthtopics/Documents/091127_Influenza_AH1N1_Situation_Report_0900hrs.pdf. 2009 (Accessed November 27, 2009)
57. Davies A, Jones D, Bailey M, et al; Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal Membrane Oxygenation for 2009 Influenza A (H1N1) Acute Respiratory Distress Syndrome. JAMA 2009;302:1888-1895.
58. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009;302:1872-1879.
59. Dominguez-Cherit G, Lapinsky S.E, Macias A.E, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009;302:1880-1887.
60. Jain S, Kamimoto L, Bramley A.M, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-1944.
61. WHO, Public health signifcance of virus mutation detected in Norway: Pandemic (H1N1) 2009 briefng note 17. http://www.who.int/csr/disease/swineflu/notes/briefing_20091120/en/index.html, 2009 (Accessed February 23, 2010)
62. Osterhaus A.D. Rimmelzwaan G.F, Martina B.E, Bestebroer T.M, Fouchier R.A. Influenza B virus in seals. Science 2000;288:1051-1053.
63. Moriuchi H, Katsushima N, Nishimura H, Nakamura K, Numazaki Y. Community-acquired influenza C virus infection in children. J Pediatr 1991;118:235-238.
64. ÓCallaghan R.J, Gohd R.S, Labat D.D. Human antibody to influenza C virus: its age-related distribution and distinction from receptor analogs. Infect Immun 1980;30:500-505.